A Phase 2b Randomized, Double-blind, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn’s Disease

Project: Research

Project Details

Project Description

HREC Reference Number: HREC/89328/MH-2022
SSA Reference Number: SSA/89328/MonH-2023-365209(v1)
Monash Health Local Reference: RES-23-0000-241X
Effective start/end date15/05/2314/05/28